Anti-Cetuximab Polyclonal Antibody|抗西妥昔单抗多克隆抗体(靶标：西妥昔单抗（抗EGFR单抗）)
- 货号：RB9TAF004014
- 价格：面议
- 点击：196
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Rabbit |
| 克隆性 | Polyclonal |
| 抗体亚型 | IgG |
| 纯化方式 | Purified by antigen affinity column. |
| 内毒素水平 | Please contact with the lab for this information. |
| 应用 | ELISA |
| 特异性 | The product is specific for Cetuximab. This antibody serves as an excellent positive control for Cetuximab immunogenicity (ADA) assays. |
| 靶标 | Rabbit polyclonal to Erbitux. |
| 免疫原 | Cetuximab |
| 储存缓冲液 | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| 稳定性和储存 | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| 产品使用说明 | ELISA:1:5000-1:20000;IHC:1:50-1:500;WB:1:500-1:2000 |
| 登录号 | CAS: 205923-56-4 |
| 背景信息 | Cetuximab (Erbitux) is a chimeric (mouse/human) monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab, as an epidermal growth factor receptor (EGFR) inhibitor, binds to EGFR. • Polyclonal antibody-induced downregulation of HER1/EGFR and HER2 surpasses the effect of combinations of specific registered antibodies., PMID:36408164 • Polyclonal antitumor immunoglobulin may play a role in ovarian cancer adjuvant therapy., PMID:21255939 |
| 备注 | For research use only. |
相关产品:
| 产品名称 | 点击数 |
|---|---|
| 炔诺酮单抗 | 5617 |
| 磺胺氯吡嗪单抗 | 5627 |
| 呋喃苯烯酸钠单抗 | 5508 |
| 呋喃它酮代谢物（2-NPAMOZ）单抗 | 5463 |
| 呋喃西林代谢物（2-NPSEM）单抗 | 5322 |
| 磺胺喹恶啉单抗 | 5547 |
| 苯丙酸诺龙单抗 | 5444 |
| 司帕沙星单抗 | 5259 |
| 妥布霉素单抗 | 5524 |
| 甲氧氯普胺单抗 | 5406 |
| 莫能菌素单抗 | 5492 |
| 多粘菌素B（粘菌素）单抗 | 5820 |
| 磺胺类单抗 | 5631 |
| 托灭酸（托芬那酸）单抗 | 5422 |
| 卡洛芬单抗 | 5362 |
| 喹乙醇代谢物MQCA单抗 | 5508 |
| 氟尼辛单抗 | 5413 |
| 磺胺二甲嘧啶（SM2）单抗 | 5243 |
| 诺龙（19-去甲睾酮）单抗 | 5366 |
| 阿苯达唑-2-氨基砜单抗 | 5320 |